10 Southern California-based Companies Selected to Compete for the Quick Pitch Title at October 4th Event
SAN DIEGO, Calif., September 4, 2012 ; Tech Coast Angels (TCA), the largest angel investor network in the United States and the number one source of startup funding in Southern California, announced the 10 finalists for their Sixth Annual Quick Pitch Competition. The finalists will present at the October 4th competition to an expert panel of judges, and an audience of more than 500 leaders within the entrepreneurial community.
Each two-minute pitch will be judged on substance and...
Largest Angel Network in United States Invests in 17 Innovative Companies Across Broad Range of Industries
IRVINE, Calif. – August 15, 2012 – Tech Coast Angels (TCA) raised more than $10 million of total investment in 17 innovative companies, including $4,571,000 of direct TCA investment, during the first half of 2012 via the group’s five networks (Los Angeles, Orange County, San Diego, Central Coast, and Inland Empire). The investment portfolio for the period spans a wide spectrum of young, innovative companies -- from mobile advertising platforms and social...
By JAN NORMAN / ORANGE COUNTY REGISTER
One in every $4 that angel investors put into young growing companies over the past year has gone to a California startup, according to the Halo Report.
This report is produced by Angel Resource Institute, Silicon Valley Bank based on data by CB Insights, which collects data on private companies, their investors and inquirers
Irvine-based Tech Coast Angels is among the most active angel groups in the United States over the past 12 months. TCA has about 300 members in five regional...
At 28, Winning the War Against Counterfeit Drugs
Fresh out of Dartmouth, Nathan Sigworth talked global pharma companies into believing he had a better way to fight fake drugs in India.
Helping the poor is far from the easiest way to make money, but 28-year old Nathan Sigworth has found a way to make it pay.
He’s the CEO and co-founder of PharmaSecure, a start-up that helps drug companies combat counterfeit medication in the developing world. Dually headquartered in Lebanon, New Hampshire and Gurgaon, India,...
Flu treatment developer Gemmus Pharma Inc. raised about $1.5 million in a Series A funding led by a syndicate of angel investor groups.
Gemmus, housed in the Mission Bay Innovation Center in the FibroGen building in San Francisco, is targeting a receptor that plays a role in the anti-inflammatory response to viral infections. That approach, the company says, makes it so its treatment isn't susceptible to viral resistance.
A Gemmus spokeswoman said the company initially sought to raise at least $1.2 million.
The round was led by the Life Science Angels and included BlueTree Allied...
By Andrea Chang
April 25, 2012, 3:46 p.m.
A minute and a half isn’t a lot of time, but for 11 local entrepreneurs, 90 seconds was all they had to pitch their start-up ideas to a panel of judges Tuesday.
More than 175 start-ups applied to participate in the 7th annual Fast Pitch Competition, held at UCLA’s Anderson School of Management...